tolvaptan has been researched along with Dementia Praecox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albazzaz, A; Czerwiec, F; Goldman, M; Jessani, M; Josiassen, RC; Lee, J; Orlandi, C; Ouyang, J; Shaughnessy, RA | 1 |
| Goldman, MB | 1 |
1 review(s) available for tolvaptan and Dementia Praecox
| Article | Year |
|---|---|
The assessment and treatment of water imbalance in patients with psychosis.
Topics: Antidiuretic Hormone Receptor Antagonists; Antimanic Agents; Antipsychotic Agents; Benzazepines; Clozapine; Combined Modality Therapy; Diagnosis, Differential; Drinking; Humans; Hyponatremia; Lithium Carbonate; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Risk Factors; Schizophrenia; Schizophrenic Psychology; Sodium Chloride Symporter Inhibitors; Tolvaptan; Water Deprivation; Water Intoxication; Water-Electrolyte Balance | 2010 |
1 trial(s) available for tolvaptan and Dementia Praecox
| Article | Year |
|---|---|
Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia.
Topics: Adult; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyponatremia; Male; Middle Aged; Schizophrenia; Time Factors; Tolvaptan | 2008 |